Evidence map›Paper›PMID 35864015›Full record

ArticleAmerican journal of preventive medicine2022

COVID-19 Vaccination and Intent for Vaccination of Adults With Reported Medical Conditions.

Peng-Jun Lu, Mei-Chuan Hung, Hannah L Jackson, Jennifer L Kriss, Anup Srivastav, David Yankey, Tammy A Santibanez, James Tseryuan Lee, Lu Meng, Hilda Razzaghi and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of preventive medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Peng-Jun LuImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: plu@cdc.gov.
Mei-Chuan HungImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia; Leidos Inc., Atlanta, Georgia.
Hannah L JacksonCDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jennifer L KrissImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Anup SrivastavImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia; Leidos Inc., Atlanta, Georgia.
David YankeyImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Tammy A SantibanezImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
James Tseryuan LeeImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lu MengCDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Hilda RazzaghiImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Carla L BlackImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Laurie D Elam-EvansImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia.
James A SingletonImmunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia; CDC COVID-19 Response Team, Global Health Protection and Security, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USLeidos (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIndividuals with certain medical conditions are at substantially increased risk for severe illness from COVID-19. The purpose of this study is to assess COVID-19 vaccination among U.S. adults with reported medical conditions.

methodsData from the National Immunization Survey-Adult COVID Module collected during August 1-September 25, 2021 were analyzed in 2022 to assess COVID-19 vaccination status, intent, vaccine confidence, behavior, and experience among adults with reported medical conditions. Unadjusted and age-adjusted prevalence ratios (PRs and APRs) were generated using logistic regression and predictive marginals.

resultsOverall, COVID-19 vaccination coverage with ≥1 dose was 81.8% among adults with reported medical conditions, and coverage was significantly higher compared with those without such conditions (70.3%) Among adults aged ≥18 years with medical conditions, COVID-19 vaccination coverage was significantly higher among those with a provider recommendation (86.5%) than those without (76.5%). Among all respondents, 9.2% of unvaccinated adults with medical conditions reported they were willing or open to vaccination. Adults who reported high risk medical conditions were more likely to report receiving a provider recommendation, often or always wearing masks during the last 7 days, concerning about getting COVID-19, thinking the vaccine is safe, and believing a COVID-19 vaccine is important for protection from COVID-19 infection than those without such conditions.

conclusionsApproximately 18.0% of those with reported medical conditions were unvaccinated. Receiving a provider recommendation was significantly associated with vaccination, reinforcing that provider recommendation is an important approach to increase vaccination coverage. Ensuring access to vaccine, addressing vaccination barriers, and increasing vaccine confidence can improve vaccination coverage among unvaccinated adults.

Indexed as

COVID-19VaccinesAdolescentAdultCOVID-19 VaccinesHumansVaccinationVaccination CoverageCOVID-19 VaccinesVaccines

Identifiers

PMID35864015
PMCPMC9234053
OpenAlexW4283587133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.